SCHEMBL19766935

SCHEMBL19766935

C=C(OCCCC)C(=O)OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
TSHR P16473 5/20 0.62
L3MBTL1 Q9Y468 4/20 0.62
MAPK1 P28482 4/20 0.62
TDP1 Q9NUW8 3/20 0.62
CYP3A4 P08684 2/20 0.62
CETP P11597 3/20 0.46
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.43
ESR1 P03372 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
NR1H2 P55055 1/20 0.43
RNASEL Q05823 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20360097 0.94 TSHR (0.62) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL9790736 0.87 ALDH1A1 (0.69) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL28801572 0.84 ALDH1A1 (0.51) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL6660310 0.84 ALDH1A1 (0.55) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL9562211 0.83 ALDH1A1 (0.63) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL10599434 0.82 TSHR (0.56) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL1920842 0.82 L3MBTL1 (0.56) ALDH1A1TSHRL3MBTL1MAPK1TDP1
Propene SCHEMBL28153646 0.82 TSHR (0.56) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL20023007 0.81 TSHR (0.61) ALDH1A1TSHRL3MBTL1MAPK1TDP1
SCHEMBL20023005 0.81 TSHR (0.61) ALDH1A1TSHRL3MBTL1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180009807-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2018-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009807-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 ALDH1A1 1267/4885TSHR 1619/4885L3MBTL1 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.